Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities:
Net income (loss)	$ (471,751)	$ (85,532)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization, including goodwill impairment	482,445	153,357
Impairment of Intangible Assets, Finite-lived	68,763	0
Deferred income tax provision (benefit)	(8,211)	(8,171)
Inventory Write-down	7,038	0
Net loss (gain) on sales of property and equipment and cost method investment	1,597	(4,935)
Noncash compensation	6,252	8,202
Other Noncash Income (Expense)	(1,838)	0
Increase (Decrease) in Accounts Receivable	(87,999)	(51,629)
Excluding the effects of acquisitions, increase (decrease) in cash from:
Inventory	19,179	(10,765)
Proceeds from Sale of Debt Securities, Available-for-sale	12,840	0
Other operating assets	(4,639)	16,502
Currency translation effect on working capital, excluding cash	3,256	(4,375)
Current liabilities	(158,496)	(340)
Other operating liabilities	(12,071)	(3,405)
Total adjustments to net income (loss)	504,114	197,699
Net Cash Provided by (Used in) Operating Activities	32,363	112,167
Cash Flows from Investing Activities:
Purchases of property and equipment	(45,840)	(128,847)
Distributions of capital from unconsolidated affiliates	5,374	2,395
Proceeds from Sale of Productive Assets	1,752	6,406
Net Cash Provided by (Used in) Investing Activities	(38,714)	(120,046)
Cash Flows from Financing Activities:
Other financing activities	(1,725)	(2,320)
Net Cash Provided by (Used in) Financing Activities	(1,725)	(2,320)
Effect of exchange rates on cash	(6,802)	(3,737)
Net Increase (Decrease) in Cash and Cash Equivalents	(14,878)	(13,936)
Cash and Cash Equivalents—Beginning of Period	373,655	354,259
Cash and Cash Equivalents—End of Period	$ 358,777	$ 340,323